Product/Composition:- | Pioglitazone + Glimepiride Tablets |
---|---|
Strength:- | Pioglitazone 15 mg/30 mg + Glimepiride 1 mg/2 mg/ 4 mg |
Form:- | Tablets |
Reference Brands:- | Duetact |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
This combination works synergistically to control blood glucose in type 2 diabetes. Pioglitazone, a thiazolidinedione, improves insulin sensitivity in muscle and fat, while Glimepiride, a sulfonylurea, stimulates insulin release from pancreatic β-cells. Together, they enhance glycemic control, reduce insulin resistance, and lower HbA1c levels effectively.
Pioglitazone and Glimepiride combination tablets are used in managing type 2 diabetes mellitus by enhancing insulin sensitivity and stimulating pancreatic insulin secretion. In the USA, fixed-dose combinations are less commonly marketed, with Actoplus Met (Pioglitazone + Metformin) being more prevalent. However, some Pioglitazone–Glimepiride formulations are approved in select EU countries and widely available as generics in Asia. In the EU, products must meet EMA standards for bioequivalence and fixed-dose rationale. These combinations are prescribed when monotherapy fails to control blood glucose. Pharmatradz.com connects buyers with certified suppliers offering GMP-compliant combination antidiabetic medications globally, including Pioglitazone-Glimepiride tablets.